Cite
Focus shifts in the Hungarian reimbursement system. Funding of orphan medicinal products for rare disease patients in Hungary: Financing of orphan medicines
MLA
Mária Judit Molnár, et al. “Focus Shifts in the Hungarian Reimbursement System. Funding of Orphan Medicinal Products for Rare Disease Patients in Hungary: Financing of Orphan Medicines.” Orvosi Hetilap, vol. 155, Nov. 2014, pp. 1735–41. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0d8e60c0d3c0d8bad56d07fac4deb752&authtype=sso&custid=ns315887.
APA
Mária Judit Molnár, Márta Szegedi, György Kosztolányi, & Imre Boncz. (2014). Focus shifts in the Hungarian reimbursement system. Funding of orphan medicinal products for rare disease patients in Hungary: Financing of orphan medicines. Orvosi Hetilap, 155, 1735–1741.
Chicago
Mária Judit Molnár, Márta Szegedi, György Kosztolányi, and Imre Boncz. 2014. “Focus Shifts in the Hungarian Reimbursement System. Funding of Orphan Medicinal Products for Rare Disease Patients in Hungary: Financing of Orphan Medicines.” Orvosi Hetilap 155 (November): 1735–41. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0d8e60c0d3c0d8bad56d07fac4deb752&authtype=sso&custid=ns315887.